Gabriel Morris
Net worth: 4 M $ as of 2025-12-30
Profile
Gabriel A. Morris currently works at Immix Biopharma, Inc., as Chief Financial Officer & Director from 2021, Alwaysraise LLC, as Managing Partner from 2020, and Nexcella, Inc., as President.
Mr. Morris also formerly worked at Campbell & Co. LP, as Chief Operating Officer and ZAP Surgical Systems, Inc., as Chief Financial Officer from 2019 to 2020.
Mr. Morris received his undergraduate degree from The Trustees of Columbia University in The City of New York.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-12-09 | 742,414 ( 1.41% ) | 4 M $ | 2025-12-30 |
Latest news about Gabriel Morris
Gabriel Morris active positions
| Companies | Position | Start |
|---|---|---|
| IMMIX BIOPHARMA, INC. | Director of Finance/CFO | 2021-02-28 |
Alwaysraise LLC | Corporate Officer/Principal | 2019-12-31 |
Nexcella, Inc.
Nexcella, Inc. Develops cell therapies | President | - |
Former positions of Gabriel Morris
| Companies | Position | End |
|---|---|---|
Campbell & Co. LP
Campbell & Co. LP Investment ManagersFinance Provides investment management services | Chief Operating Officer | 2021-01-02 |
ZAP Surgical Systems, Inc.
ZAP Surgical Systems, Inc. Operates as a gyroscopic radiosurgery platform | Director of Finance/CFO | 2019-12-31 |
Training of Gabriel Morris
Experiences
Positions held
Linked companies
| Private companies | 6 |
|---|---|
Campbell & Co. LP
Campbell & Co. LP Investment ManagersFinance Provides investment management services | Finance |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immix Biopharma, Inc.
Immix Biopharma, Inc. Operates as a biopharmaceutical company that develops therapies for cancer patients | |
ZAP Surgical Systems, Inc.
ZAP Surgical Systems, Inc. Operates as a gyroscopic radiosurgery platform | |
Alwaysraise LLC | |
Nexcella, Inc.
Nexcella, Inc. Develops cell therapies |
- Stock Market
- Insiders
- Gabriel Morris
















